Streetbeat News

Products Services

NSANY

Nissan has announced plans to manufacture lithium-ion batteries using lower-cost materials, aiming to install them in electric vehicles (EVs) sold in emerging markets by 2026. This move is part of Nissan's strategy to make EVs more affordable and accessible in these regions, potentially increasing the company's market share in the growing EV sector.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:33 pm

VIEW

View Inc, a leader in smart glass, has been granted a European patent for 'Electrochromic Device Fabrication Method And Insulated Glass Unit Comprising An Electrochromic Device'. This patent could strengthen View's intellectual property portfolio and potentially enhance its competitive edge in the smart glass market in Europe.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:32 pm

STLA

Stellantis NV (NYSE:STLA) has begun in-house production of hydrogen fuel cell commercial vans in Europe, with facilities in Hordain, France, and Gliwice, Poland. The company aims to expand its zero-emission vehicle range and strengthen its position in the commercial vehicle segment. The vans offer a range of up to 400-500 kilometers and refueling times of 4-5 minutes. Stellantis will produce eight hydrogen fuel cell versions of mid-size and large vans, including models from Fiat Professional, Citroën, Peugeot, and Opel/Vauxhall. Additionally, Stellantis has invested in Tiamat, a French company specializing in sodium-ion battery technology. STLA shares were down 1.16% at $20.97 in the last check.

Portfolio Pulse from Lekha Gupta

January 29, 2024 | 6:24 pm

LLY

NVO

Eli Lilly (LLY) is in talks with the German government to allow public health coverage for weight-loss treatments, following EU approval for its drug Mounjaro. The company plans to invest €2 billion in a German production plant. A study showed Mounjaro is more effective than Novo Nordisk's (NVO) Ozempic for weight loss. LLY shares rose 0.59%.

Portfolio Pulse from Vandana Singh

January 29, 2024 | 6:14 pm

HSY

PFGC

Performance Food Group (PFGC) has partnered with The Hershey Company (HSY) to feature Hershey's iconic chocolate brands in its premium dessert line. This collaboration is expected to enhance PFGC's dessert offerings by incorporating well-known Hershey's chocolate products.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:07 pm

COIN

Coinbase Global, Inc. (NASDAQ:COIN) stock is trading higher, influenced by the recent increase in Bitcoin's price and a positive analyst upgrade. Bitcoin's price has risen over 8% in the past five days, positively impacting crypto-related stocks like Coinbase. Oppenheimer analyst Owen Lau upgraded Coinbase from Perform to Outperform with a price target of $160, citing potential favorable outcomes in ongoing litigation with the SEC and benefits from the approval of spot Bitcoin ETFs.

Portfolio Pulse from Erica Kollmann

January 29, 2024 | 6:07 pm

KEYS

Keysight Technologies has been validated for 3GPP Release 16 transmitter performance enhancement test cases, covering single and multiple precoding matrix indicators for 16 and 32 element transmitters. The validations, which include the first test cases for 3GPP Release 17 Enhanced Power Saving, were achieved at the Conformance Agreement Group #77 meeting in Malaga, Spain.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:05 pm

ETHUSD

On Sunday, 2,561.44 Ether (ETH) valued at approximately $5.9 million was burned due to the EIP-1159 upgrade implemented on the Ethereum blockchain, which introduced a variable base fee for transactions that is permanently removed from circulation. This has led to a net annualized issuance rate of -0.18% for Ether, indicating a move towards a deflationary currency, especially with the anticipated Ethereum 2.0 upgrade that is expected to further reduce the issuance rate.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 6:00 pm

PFE

The FDA has revised the emergency use authorization for Pfizer's COVID-19 treatment Paxlovid. The EUA-labeled Paxlovid will remain authorized until March 8, 2024, or its expiration date, whichever comes first. After this date, only FDA-approved NDA-labeled Paxlovid will be available. This transition began on November 1, 2023, and affects pharmacies and healthcare providers. The PAXCESS program will offer free Paxlovid to eligible patients until December 31, 2024. Pfizer's stock (PFE) saw a minor decrease of 0.04% to $27.46.

Portfolio Pulse from Vandana Singh

January 29, 2024 | 5:39 pm

GOOG

GOOGL

KeyBanc Capital Markets analyst Justin Patterson maintained an Overweight rating on Alphabet Inc. (GOOGL, GOOG) and increased the price target from $153 to $165, indicating an 8.42% upside potential. Patterson expects Alphabet to report solid Q4 revenue, with Google Search and YouTube offsetting a potential Cloud revenue miss. However, he anticipates an earnings miss due to a $700 million Google Pay settlement and higher NFL Sunday Ticket expenses. KeyBanc raised its revenue estimates slightly but lowered its earnings per share estimates for Q4 and 2023. Shares of Alphabet were mixed in recent trading.

Portfolio Pulse from Shanthi Rexaline

January 29, 2024 | 5:32 pm